Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States

In the US, research has established that a funding relationship exists between pharmaceutical industries and physicians, particularly cardiologists. This study aimed to fill a research gap via an in-depth data analysis of the impact that the coronavirus 2019 restrictions had on this dynamic. The pay...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Anju, Kamamoto, Sae, Shigeta, Haruki, Ozaki, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Emerging Evidence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812463/
https://www.ncbi.nlm.nih.gov/pubmed/36624880
http://dx.doi.org/10.1016/j.cjco.2023.01.001
_version_ 1784863732276396032
author Murayama, Anju
Kamamoto, Sae
Shigeta, Haruki
Ozaki, Akihiko
author_facet Murayama, Anju
Kamamoto, Sae
Shigeta, Haruki
Ozaki, Akihiko
author_sort Murayama, Anju
collection PubMed
description In the US, research has established that a funding relationship exists between pharmaceutical industries and physicians, particularly cardiologists. This study aimed to fill a research gap via an in-depth data analysis of the impact that the coronavirus 2019 restrictions had on this dynamic. The payments per cardiologist declined by 55.7% (95% confidence interval: 52.0%‒-59.0%, P < 0.001) in monetary amounts, and by 66.6% (95% confidence interval: 66.1%-67.1%, P < 0.001) in the number of payments right after the COVID-19 pandemic onset, respectively. Cardiologists must consider the ethical implications of the potential for their clinical practice to be influenced by industry payments.
format Online
Article
Text
id pubmed-9812463
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98124632023-01-05 Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States Murayama, Anju Kamamoto, Sae Shigeta, Haruki Ozaki, Akihiko CJC Open Emerging Evidence In the US, research has established that a funding relationship exists between pharmaceutical industries and physicians, particularly cardiologists. This study aimed to fill a research gap via an in-depth data analysis of the impact that the coronavirus 2019 restrictions had on this dynamic. The payments per cardiologist declined by 55.7% (95% confidence interval: 52.0%‒-59.0%, P < 0.001) in monetary amounts, and by 66.6% (95% confidence interval: 66.1%-67.1%, P < 0.001) in the number of payments right after the COVID-19 pandemic onset, respectively. Cardiologists must consider the ethical implications of the potential for their clinical practice to be influenced by industry payments. Elsevier 2023-01-05 /pmc/articles/PMC9812463/ /pubmed/36624880 http://dx.doi.org/10.1016/j.cjco.2023.01.001 Text en © 2023 The Authors
spellingShingle Emerging Evidence
Murayama, Anju
Kamamoto, Sae
Shigeta, Haruki
Ozaki, Akihiko
Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
title Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
title_full Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
title_fullStr Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
title_full_unstemmed Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
title_short Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
title_sort industry payments during the covid-19 pandemic to cardiologists in the united states
topic Emerging Evidence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812463/
https://www.ncbi.nlm.nih.gov/pubmed/36624880
http://dx.doi.org/10.1016/j.cjco.2023.01.001
work_keys_str_mv AT murayamaanju industrypaymentsduringthecovid19pandemictocardiologistsintheunitedstates
AT kamamotosae industrypaymentsduringthecovid19pandemictocardiologistsintheunitedstates
AT shigetaharuki industrypaymentsduringthecovid19pandemictocardiologistsintheunitedstates
AT ozakiakihiko industrypaymentsduringthecovid19pandemictocardiologistsintheunitedstates

Ejemplares similares